RMND5A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.886400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.991600E-01
Normal-vs-Stage2
5.453400E-01
Normal-vs-Stage3
9.313600E-01
Normal-vs-Stage4
1.737230E-01
Stage1-vs-Stage2
7.536200E-01
Stage1-vs-Stage3
6.815400E-01
Stage1-vs-Stage4
1.842010E-01
Stage2-vs-Stage3
4.108200E-01
Stage2-vs-Stage4
2.054200E-01
Stage3-vs-Stage4
2.918000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.888800E-01
Normal-vs-AfricanAmerican
3.479000E-01
Normal-vs-Asian
8.020200E-01
Caucasian-vs-AfricanAmerican
6.490000E-01
Caucasian-vs-Asian
5.648200E-01
AfricanAmerican-vs-Asian
4.143400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.063400E-01
Normal-vs-Female
7.159600E-01
Male-vs-Female
1.314770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.137800E-01
Normal-vs-Age(41-60Yrs)
3.989600E-01
Normal-vs-Age(61-80Yrs)
6.975800E-01
Normal-vs-Age(81-100Yrs)
6.173800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.676400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.494600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.634400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.913600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.871900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.468000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.500400E-01
Normal-vs-Daily Drinker
7.202200E-01
Normal-vs-Weekly Drinker
9.362400E-01
Normal-vs-Occasional Drinker
1.570050E-02
Normal-vs-Social Drinker
8.718400E-01
Non Drinker-vs-Daily Drinker
6.015400E-01
Non Drinker-vs-Weekly Drinker
6.294000E-01
Non Drinker-vs-Occasional Drinker
2.749900E-02
Non Drinker-vs-Social Drinker
8.638400E-01
Daily Drinker-vs-Weekly Drinker
4.482200E-01
Daily Drinker-vs-Occasional Drinker
7.552000E-02
Daily Drinker-vs-Social Drinker
5.059200E-01
Weekly Drinker-vs-Occasional Drinker
3.547900E-02
Weekly Drinker-vs-Social Drinker
7.486200E-01
Occasional Drinker-vs-Social Drinker
2.030400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.333600E-02
Normal-vs-Grade 2
2.443600E-02
Normal-vs-Grade 3
4.075300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.119770E-01
Grade 1-vs-Grade 3
2.893200E-01
Grade 1-vs-Grade 4
7.333600E-02
Grade 2-vs-Grade 3
4.329000E-01
Grade 2-vs-Grade 4
2.443600E-02
Grade 3-vs-Grade 4
4.075300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.257800E-01
Normal-vs-NonDiabetic
5.541000E-01
Diabetic-vs-NonDiabetic
1.052190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.165400E-01
Normal-vs-NoPancreatitis
6.227000E-01
Pancreatitis-vs-NoPancreatitis
9.695600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.526800E-01
Normal-vs-N1
5.728000E-01
N0-vs-N1
8.946600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.915240E-01
Normal-vs-TP53-NonMutant
6.045800E-01
TP53-Mutant-vs-TP53-NonMutant
2.082000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
